Is it worthwhile to treat Peyronie disease?

Area of Science:

• Urology
• Andrology
• Men's Health

Background:

• Peyronie disease (PD) natural history suggests spontaneous improvement in some untreated patients.
• This natural course may contribute to the perceived efficacy of various treatment modalities.
• Clarifying the role of treatment versus spontaneous evolution is crucial for evidence-based management.

Purpose of the Study:

• To evaluate whether medical treatments for Peyronie disease improve outcomes beyond spontaneous resolution.
• To identify key factors influencing the decision-making process for initiating PD treatment.
• To provide a nuanced perspective on the necessity and timing of Peyronie disease interventions.

Main Methods:

• Comprehensive review of existing literature on Peyronie disease natural history and treatment outcomes.
• Analysis of the authors' previous clinical experience and patient data.
• Evaluation of factors including symptom presentation, psychological distress, treatment risks, and symptom duration.

Main Results:

• While PD treatments do not substantially increase the overall percentage of symptom amelioration compared to spontaneous evolution, they do accelerate the improvement process.
• Specific factors such as symptom type, psychological impact, potential treatment complications, and time from symptom onset are critical for treatment decisions.
• The efficacy of treatment is not uniform and depends on a careful assessment of individual patient circumstances.

Conclusions:

• Treatment for Peyronie disease can expedite symptom relief but does not significantly alter the ultimate recovery rates seen in natural spontaneous improvement.
• A personalized approach is necessary, considering symptom severity, patient psychological well-being, treatment risks, and the disease's temporal progression.
• The decision to treat Peyronie disease requires careful consideration of multiple factors, as there is no one-size-fits-all answer.